This interactive microlearning activity is part of a case-based series designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in improving biomarker testing and treatment for NSCLC. This specific course focuses on equity in biomarker testing and the challenges to implementing biomarker testing in the clinical workflow.
Course topics include:
- EGFR mutations
- Ultra-stat testing
- Challenges in implementing biomarker testing
Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.
Learning Objectives
Upon completion of this activity, you will be able to:
- Understand the role of molecular biomarker testing in guiding targeted therapy decisions for lung cancer patients
- Explain the importance of timely biomarker testing and its impact on treatment initiation
- Recognize clinical and demographic factors that influence the likelihood of specific biomarker mutations in NSCLC
- Analyze common challenges and barriers to implementing biomarker testing in clinical workflow
Faculty
Diana Ionescu, M.D.
Professor, Clinical Pathology
University of British Columbia, Vancouver, Canada
Faculty Disclosures
All relevant relationships for Dr. Diana Ionescu Lo have been mitigated.
Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
The ASCP designates this activity for a maximum of .25 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this activity for a maximum of .25 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation
To complete the activity and receive credit, the participant must attend the program. CME certificates will be provided on-line.
Commercial Support
This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.